Latest market price
94.79
-1.77-1.83%
OverviewShort InterestFilings
SYREQT63Spyre Therapeutics, Inc.·NASDAQ
94.79-1.83%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 09, 2026SC 13D/ABeneficial ownership statement (active, amended)
Oct 07, 20268-KCurrent report
Oct 06, 2026424B5Prospectus
Oct 05, 2026424B5Prospectus
Oct 02, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Oct 01, 2026SC 13GBeneficial ownership statement (passive)
Sep 08, 20268-KCurrent report
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 01, 2026144Notice of proposed sale of restricted securities
Aug 25, 20268-KCurrent report
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 10, 20264Statement of changes in beneficial ownership
Aug 07, 2026144Notice of proposed sale of restricted securities
Aug 07, 2026144Notice of proposed sale of restricted securities
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 20264Statement of changes in beneficial ownership
Aug 04, 20268-KCurrent report
Aug 04, 202610-QQuarterly report
Aug 03, 2026144Notice of proposed sale of restricted securities
Jul 02, 20264Statement of changes in beneficial ownership
#1 / 25 of 463
Page
▼
/ 19